Search

Author/Creator Ford, Catriona A

1. CXCR2 inhibition enables NASH-HCC immunotherapy. Issue 10 (27th April 2022)

Authors:
Leslie, Jack; Mackey, John B G; Jamieson, Thomas; Ramon-Gil, Erik; Drake, Thomas M; Fercoq, Frédéric; Clark, William; Gilroy, Kathryn; Hedley, Ann; Nixon, Colin; Luli, Saimir; Laszczewska, Maja; Pinyol, Roser; Esteban-Fabró, Roger; Willoughby, Catherine E; Haber, Philipp K; Andreu-Oller, Carmen; ...
Journal:
Gut
Issue:
Volume 71:Issue 10(2022)
Page Start:
2093
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer. Issue 3 (11th January 2022)

Authors:
Blomme, Arnaud; Peter, Coralie; Mui, Ernest; Rodriguez Blanco, Giovanny; An, Ning; Mason, Louise M; Jamieson, Lauren E; McGregor, Grace H; Lilla, Sergio; Ntala, Chara; Patel, Rachana; Thiry, Marc; Kung, Sonia H Y; Leclercq, Marine; Ford, Catriona A; Rushworth, Linda K; McGarry, David J; Mason, Su...
Journal:
EMBO molecular medicine
Issue:
Volume 14:Issue 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search